Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia.

Ther Adv Hematol · 2019 · PMC6535741 · PMID 31205644

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significancep = 0.10so close (0.05 < p ≤ 0.1)

The 4-year OS was also higher in the rituximab group, although this did not reach statistical significance (61% versus 50%; p = 0.10).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.